Abridge
AB
Abridge provides an AI documentation platform for clinicians and health systems. It captures patient visits and produces structured clinical notes and summaries for electronic health record workflows. The software links generated text to supporting moments in the conversation for review and audit.
Founded by Zachary Lipton (CTO, Co-Founder, CSO), Shivdev Rao (CEO, Founder), Sandeep Konam (Co-Founder), Florian Metze (Co-founder)
Blended valuation$6B$6B secondary
Valuation history
Weekly blended valuation with priced funding rounds marked on the timeline.
$6.5B
blended valuationfunding round
May 31, 2021$0Oct 12, 2026
All rounds
8 funding rounds, newest first.
| Round | Announced | Raised | Post-money |
|---|---|---|---|
| Series E | Jun 24, 2025 | $300M | $5.3B |
| Series D | Feb 17, 2025 | $250M | $2.8B |
| Series C | Feb 23, 2024 | $150M | $850M |
| Series B | Oct 26, 2023 | $30M | $700M |
| Series A | Aug 11, 2022 | $12.5M | $75M |
Join Legion to view all 8 rounds.Sign in to Legion
Investors
36 investors across all rounds.
- PVPillar VC
- SCSpark Capital
- USUnion Square Ventures
- AHAndreessen Horowitz
- LVLightspeed Venture Partners
- EGElad Gil
- IVInstitutional Venture Partners
- KVKhosla Ventures
- RERedpoint
- BVBessemer Venture Partners
Only Legion members can view the full investor roster. Sign in to Legion
Secondary market activity
Recent buy and sell interest for Abridge shares on the secondary market.
| Kind | Implied valuation | Price / share | Date |
|---|---|---|---|
| $5.7B | — | Oct 16, 2026 | |
| $6.7B | $200.00 | Oct 16, 2026 | |
| $6.7B | $200.00 | Oct 6, 2026 |
Invest in the private markets on Legion
Registered users see full trading activity, every investor, rankings, and live deals.
Data as of Oct 19, 2026. Valuations are estimates blended from primary and secondary-market signals — not investment advice.